Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Paratus Sciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
Paratus Sciences

Paratus Sciences

Series A

Paratus Sciences: A biotech start-up leveraging bat biology for innovative human health solutions.

HQ
New York City, NY, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Paratus Sciences, a biotech start-up, was founded with the mission to enhance human health and security by studying bat biology. The company aims to unlock the secrets of the bat genome to identify and develop potential therapeutics for various diseases. Their market focus is on innovative health solutions derived from unique biological insights, particularly those that can lead to breakthroughs in disease treatment and prevention.

Notable figures affiliated with Paratus Sciences include leading scientists and researchers in the field of genomics and virology. The company has attracted significant interest from investors focused on biotech innovations. Key achievements include pioneering research that has opened new avenues for therapeutic development. Paratus Sciences' impact lies in its potential to revolutionize health security and treatment options through its novel approach to leveraging bat biology.

Paratus Sciences - Similar Companies

Petri Bio logo

Petri Bio

petribio.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Enavate Sciences logo

Enavate Sciences

Faze Medicines logo

Faze Medicines

fazemed.com

Parion Sciences logo

Parion Sciences

parion.com

Fauna Bio logo

Fauna Bio

faunabio.com

Marlinspike Therapeutics logo

Marlinspike Therapeutics

Parthenon Therapeutics logo

Parthenon Therapeutics

parthenontx.com

Paragon Biosciences logo

Paragon Biosciences

paragonbiosci.com

Parallel Bio logo

Parallel Bio

parallel.bio

Bioventure Partners logo

Bioventure Partners

BlueTurtleBio Technologies logo

BlueTurtleBio Technologies

blueturtlebio.com

Galatea Bio logo

Galatea Bio

galatea.bio

MarvelBiome logo

MarvelBiome

marvelbiome.com

Curie.Bio logo

Curie.Bio

curie.bio

Paratus Sciences - Quick Facts

Who are Paratus Sciences' competitors?

Companies similar to Paratus Sciences include Petri Bio, ProFound Therapeutics, Enavate Sciences and Faze Medicines.

When was Paratus Sciences founded?

Paratus Sciences was founded in 2021.

Where is Paratus Sciences' headquarters located?

Paratus Sciences' headquarters is located in New York City, NY, US.

When was Paratus Sciences' last funding round?

Paratus Sciences' most recent funding round was for $100M (USD) in February 2023.

How much has Paratus Sciences raised to-date?

As of Feb 27, 2023, Paratus Sciences has raised a total of $100M (USD).

How many employees does Paratus Sciences have?

Paratus Sciences has 38 employees as of Feb 5, 2024.

Paratus Sciences - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Health Solutions
  • Therapeutics
Tags
  • Healthtech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified